Amoxicillin for Haemophilus influenzae Type B Respiratory Infections
Understanding the Resistance Problem
- 20-30% of H. influenzae strains produce β-lactamase enzymes, rendering them resistant to amoxicillin and other penicillins, according to the European Respiratory Journal 1, 2
- Current surveillance data shows that only 58-82% of H. influenzae isolates remain susceptible to regular- and high-dose amoxicillin, as reported in Pediatrics 3, 4
Recommended Treatment Approach
- The American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in a 14:1 ratio, given in 2 divided doses) as the preferred first-line agent for acute otitis media when β-lactamase-producing H. influenzae coverage is desired 3, 4
- The European Respiratory Society suggests that amoxicillin-clavulanate must be used in high dosages (875/125 mg or preferably 2000/125 mg twice daily) to achieve concentrations above the MIC of resistant strains for COPD exacerbations 1, 2
Alternative Agents When Amoxicillin-Clavulanate Cannot Be Used
- The American Academy of Pediatrics recommends cefdinir, cefuroxime, or cefpodoxime (second-generation cephalosporins with activity against β-lactamase producers) as alternative agents for penicillin-allergic patients or treatment failures 3
- The European Respiratory Society suggests respiratory fluoroquinolones (levofloxacin, moxifloxacin) for adults with COPD as an alternative to amoxicillin-clavulanate 1, 2
Critical Pitfalls to Avoid
- The American Academy of Pediatrics advises against using plain amoxicillin monotherapy when H. influenzae is documented or strongly suspected, especially in patients with recent antibiotic exposure 3
- The European Respiratory Society notes that macrolides are inadequate for H. influenzae, as most strains are resistant to clarithromycin, though azithromycin has some activity 1
Clinical Context: When Hib Is Actually the Concern
- The Journal of Microbiology, Immunology and Infection reports that true Hib disease has become rare in vaccinated populations, and most H. influenzae respiratory infections today are caused by non-typeable H. influenzae (NTHi) strains 5
- The Journal of Microbiology, Immunology and Infection suggests that amoxicillin-clavulanate is preferred over amoxicillin alone for documented or suspected H. influenzae respiratory infections 5